Study of lower radiation and chemo for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of squamous cell carcinoma of the head and neck.
- Your cancer must not be in the nasopharynx, nasal cavity, paranasal sinuses, oral cavity, salivary glands, or thyroid.
- If your cancer is in the oropharynx or of unknown origin, it must test negative for p16.
- Your cancer stage must be T0-3, N1-2C, M0 (no distant spread) based on the AJCC 7th edition.
- You must be at least 18 years old.
- You must not have had prior radiation or chemotherapy for this cancer.
- You must have adequate blood counts, kidney, and liver function.
- If you are able to become pregnant, you must have a negative pregnancy test before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a special scan (F-MISO-PET) to see areas of low oxygen in head and neck cancer. The radiation dose is then customized to give higher doses to those low-oxygen areas, which may improve the chance of controlling the tumor.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This study tests whether giving less radiation after surgery is as effective as standard radiation for people with a specific type of neck cancer that started somewhere unknown. It aims to reduce side effects while keeping the cancer from coming back.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.